P/E ratio for InfuSystem (INFU)
P/E ratio as of June 2023 (TTM): N/A
According to InfuSystem's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2021 the company had a P/E ratio of 243.
P/E ratio history for InfuSystem from 2008 to 2022
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2021 | 243 | 1027.04% |
| 2020 | 21.6 | -82.29% |
| 2019 | 122 | -277.12% |
| 2018 | -68.8 | 2652% |
| 2017 | -2.50 | -103.18% |
| 2016 | 78.5 | 316% |
| 2015 | 18.9 | -4.13% |
| 2014 | 19.7 | |
| 2012 | -21.4 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 Premier PINC | 16.8 | N/A | 🇺🇸 USA |
 DexCom DXCM | 139 | N/A | 🇺🇸 USA |
 CorVel Corporation
CRVL | 53.1 | N/A | 🇺🇸 USA |
 Biolase
BIOL | -0.0187 | N/A | 🇺🇸 USA |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.